These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3040550)
1. Immunologic status, granulocyte chemotaxis and antibodies to HTLVIII/LAV in haemophiliacs treated with clotting factor concentrates. Gamba G; Ippoliti G; Bajani G; Ricevuti G; Mazzone A; Badarida G; Gobbi P; Geroldi D; Ascari E Haematologica; 1987; 72(2):129-35. PubMed ID: 3040550 [No Abstract] [Full Text] [Related]
2. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS. Chorba TL; Jason JM; Ramsey RB; Lechner K; Pabinger-Fasching I; Kalyanaraman VS; McDougal JS; Cabradilla CD; Tregillus LC; Lawrence DN Thromb Haemost; 1985 Apr; 53(2):180-2. PubMed ID: 2992112 [TBL] [Abstract][Full Text] [Related]
3. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies]. Aymard JP; Janot C; Briquel ME; André E; Schooneman F; Vigneron C; Legras B; Alexandre P; Streiff F Pathol Biol (Paris); 1985 Dec; 33(10):951-6. PubMed ID: 3005949 [TBL] [Abstract][Full Text] [Related]
4. HTLV III antibodies and immunological alterations in hemophilia patients. Seifried E; Pindur G; Stötter H; Porzsolt F; Rasche H; Erfle V; Hehlmann R; Heimpel H Klin Wochenschr; 1986 Feb; 64(3):115-24. PubMed ID: 3005759 [TBL] [Abstract][Full Text] [Related]
5. [Systematic detection of anti-LAV/HTLV-III antibodies in blood donors and hemophiliacs]. Muncunill J; Forteza A; Forner N; Forteza-Rei J Med Clin (Barc); 1986 Apr; 86(13):565. PubMed ID: 3012224 [No Abstract] [Full Text] [Related]
6. [The occurrence of LAV/HTLV III antibodies in patients with hemophilia in the County of Funen]. Larsen FS; Høst A; Munk-Andersen G Ugeskr Laeger; 1986 Mar; 148(14):865-7. PubMed ID: 3010526 [No Abstract] [Full Text] [Related]
7. HIV antibody status and immunological abnormalities in Polish haemophiliacs. Lopaciuk S; Kacperska E; Gloskowska-Moraczewska Z; Maslanka K; Uhrynowska M; Kraj M; Seyfried H Thromb Haemost; 1987 Feb; 57(1):41-3. PubMed ID: 3495899 [TBL] [Abstract][Full Text] [Related]
8. Absence of antibodies to LAV/HTLV-III in haemophiliacs treated with heat-treated factor VIII concentrate of American origin. Felding P; Nilsson IM; Hansson BG; Biberfeld G Lancet; 1985 Oct; 2(8459):832-3. PubMed ID: 2864551 [No Abstract] [Full Text] [Related]
9. Correlation of antibodies to LAV/HTLV III in hemophiliacs with the use of virus-inactivated clotting factors. Dietz B; Klose HJ; Gürtler L; Eberle J; Deinhardt F; Köhler-Vajta K; Peller P Thromb Haemost; 1986 Aug; 56(1):50-2. PubMed ID: 3095947 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis-free interval after clotting factor therapy in first infused haemophiliacs. Morfini M; Rafanelli D; Longo G; Messori A; Ferrini PR Thromb Haemost; 1986 Dec; 56(3):268-70. PubMed ID: 3563960 [TBL] [Abstract][Full Text] [Related]
12. Absence of seroconversion for HTLV-III in haemophiliacs intensively treated with heat treated factor VIII concentrate. van der Meer J; Daenen S; van Imhoff GW; de Wolf JT; Halie MR Br Med J (Clin Res Ed); 1986 Apr; 292(6527):1049. PubMed ID: 3008906 [No Abstract] [Full Text] [Related]
13. [Anti-HTLV-III in hemophilic patients in Barcelona]. Hernández Sánchez JM; Piqueras J; Vila M; Tusell J; Triginer J Sangre (Barc); 1985; 30(5):857-63. PubMed ID: 3003939 [No Abstract] [Full Text] [Related]
14. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household]. Zenz W; Muntean W; Teubl I; Beaufort F; Heinz FX Padiatr Padol; 1987; 22(1):33-41. PubMed ID: 3108827 [TBL] [Abstract][Full Text] [Related]
15. Clinical studies with treated clotting factor concentrates. Colombo M; Mannucci PM Dev Biol Stand; 1987; 67():333-6. PubMed ID: 3038639 [TBL] [Abstract][Full Text] [Related]
16. Differential prevalence of antibody to AIDS-associated retrovirus in haemophiliacs treated with Factor VIII concentrate versus cryoprecipitate: recovery of infectious virus. Koerper MA; Kaminsky LS; Levy JA Lancet; 1985 Feb; 1(8423):275. PubMed ID: 2857339 [No Abstract] [Full Text] [Related]
17. [Prevalence of anti-LAV antibodies in hemophiliacs, correlation with the immunological state]. Aymard JP; Janot C; Chermann JC; Briquel ME; Perrier P; Alexandre P; Streiff F Rev Fr Transfus Immunohematol; 1985 Jun; 28(3):261-5. PubMed ID: 2994201 [TBL] [Abstract][Full Text] [Related]
18. Absence of antibodies to HTLV-III/LAV virus in family members who administer coagulation products in home treatment programmes. Ekert H; McNaught KL Med J Aust; 1986 Jun; 144(13):722-3. PubMed ID: 3014283 [No Abstract] [Full Text] [Related]
19. Absence of antibodies to AIDS virus in haemophiliacs treated with heat-treated Factor VIII concentrate. Rouzioux C; Chamaret S; Montagnier L; Carnelli V; Rolland G; Mannucci PM Lancet; 1985 Feb; 1(8423):271-2. PubMed ID: 2857333 [No Abstract] [Full Text] [Related]
20. Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial. Lusher JM; Shapiro SS; Palascak JE; Rao AV; Levine PH; Blatt PM Trans Assoc Am Physicians; 1980; 93():175-81. PubMed ID: 6787773 [No Abstract] [Full Text] [Related] [Next] [New Search]